41
Participants
Start Date
July 31, 2009
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Furosemide
Subjects received their clinically prescribed dose of furosemide for a 3 week stabilization period, then were assessed for cardiorenal and humoral function. Subjects then had a 50% reduction of the furosemide dose for a 3 week stabilization period, and were assessed for cardiorenal and humoral function again.
Mayo Clinic, Rochester
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Mayo Clinic
OTHER